Skip Ribbon Commands
Skip to main content

Terumo wins patent suit on intravenous catheter with safety device, plans to expand sales in Southeast Asia

Terumo Corporation (TOKYO: 4543) announced it will expand its sales of its intravenous catheter with safety device.

8/5/2011 - Tokyo, Japan

B.Braun Melsungen AG ("B.Braun") initiated legal proceedings against Terumo Corporation alleging that Terumo’s intravenous catheter with safety device known as "Surshield Surflo II" infringes B.Braun’s Malaysian patent.

On July 29, 2011, Kuala Lumpur High Court, Malaysia, handed down the trial decision with the finding of non-infringement of B.Braun’s patent.

Following the result of the trial, Terumo is going to expand its safety device to intravenous catheters sold in Southeast Asian market to further contribute in enhancing safety in healthcare.

Compensation claims for the damage suffered due to the interlocutory injunction filed by B.Braun are currently under consideration.

About Terumo’s intravenous catheter with safety device

Terumo’s intravenous catheter with safety device is designed to prevent needle stick injuries in healthcare staff. Terumo’s safety devices such as "Surshield Surflo II" consist of two layers: a metallic needle positioned in the centre covered by a hollow plastic catheter on its outer layer. When the needle is pulled out after the injection, the safety device automatically covers the needle tip, therefore preventing errors and hence reducing risk to healthcare staff.

About Terumo Corporation

Terumo Corporation is a premier global medical device company with annual sales of more than 3.4 billion dollars for the fiscal year ending March 31, 2011. Founded in 1921, the company develops, manufactures and distributes world-class medical devices , such as syringes, blood bags and IV solutions. Terumo has the biggest share of the world markets for angiography guide wires and perfusion products and is a leading developer of interventional products, such as catheters and stents. For more information, visit